Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-centre Open Study to Assess the Safety and Efficacy of Subgam® Given Via the Subcutaneous Route in Primary Antibody Deficient Patients.

NCT02247141 is registered in ClinicalTrials.gov with Bio Products Laboratory as lead sponsor.

NCT NCT02247141
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02247141 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-centre Open Study to Assess the Safety and Efficacy of Subgam® Given Via the Subcutaneous Route in Primary Antibody Deficient Patients.
Lead sponsor
Bio Products Laboratory
Phase
Phase 3
Overall status
Completed
Start date
June 30, 2000
Completion date
Not reported
Enrollment
Not reported
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

primary antibody deficiency